Advertisement

Search Results for "glenmark"

Forbes List Logo
Glenmark Q3 FY17 net rises by 143%
Robust operating performance in the US business helps Glenmark post stellar earnings in an otherwise forgettable quarter for Indian pharma
ByAveek Datta
Glenmark might be selling its API business. Why?
ByNaini Thaker
The Complex Economics of Cancer Care
BySeema Singh
New Drugs at Generics' Price: Pipe Dream or Possibility?
BySeema Singh
Biocon-Pfizer Breakup: Why Diabetes Alliances Don't Work for Indian pharma?
BySeema Singh

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement